Search

February 08, 2024, Becker's ASC Review
Malpractice Mega-Verdicts Hit Record High
Robert White, President of The Doctors Company and TDC Group, discusses how a rollback of tort reform could be a factor in the rise of nuclear malpractice verdicts.

Video Sep 11, 2024
Is This Healthcare's AI Moment?
Robert Wachter, MD, Internist; Chair, Department of Medicine, University of California, San Francisco; and Member of the Board of Governors for The Doctors Company, part of TDC Group, asks top experts who gathered at the TDC Group 2024 Executive Advisory Board Meeting, “Is this healthcare’s AI moment?”

Closed Claims Studies
Get data-driven insights on the top risks by specialty, practice location, and technology, including EHRs.

Professional Education
Alzheimer's 8: Dementia Update for PCPs: Disease-Modifying Medications Risks and Benefits
A panel of dementia specialists provide up-to-date information on new disease-modifying medications receiving FDA approval, but with specific candidate criteria. Practitioners will learn how these medications work, which of their patients may benefit, how to identify and address risks, and how to effectively communicate with patients and family members. [1.50 AMA PRA Category 1 Credits™, 1.50 Contact Hours (ANCC)]

Stay in the Know

Sign up for The Doctor’s Practice.

Our e-newsletter features timely articles, videos, and guides on a range of patient safety topics.

Subscribe